Yung pt. namin sa Community Duty ay may Stroke back 15 years ago. Sa mobility is right hand yung hindi makagalaw pero nakakagalaw nmn paa then, hindi naman apektado face niya kase hindi soya asymmetrical. Gumagamit diya ng tungkod oara sa help niya para makadaan. She can eat, go to cr, change ger lower garments, on her own, pero need niya lang ng assistance sa bathing. Nag wawalk siya sa around ng kanilang bahay as her exercise. Sa speech, nahihirapan talaga dtiya mag salita pero may naiintindihan nmn kmi. Nag undergo siya ng therapy noon kaya medj nagagalaw ang Right. Occupation niya is tailoring before na stroke. This 2025,na admit siya sa hospital dahil siya difficulty breathing then diagnosed ng Community Acquired Pneumonia. then may fluid sa left liver niya then na drain through x-ray guide dahil sa may kidney disease din siya maybe because of 15 years of taking meds kaya ganun na yung side effect. May Hypertension siya and namamanage ng meds, wala namn daw siyang family history of hypertension. No lab results kase di namin nakuha and community lang 'to. Nahihirapan siya huminga sometimes pero may oxygen naman.Medications: AM: ½ cardiosel (metropolol) PM: Apıxıban 1/2 PM: Amlodipine Morning: ½ Tapazole AM: Apixibon 1/2 Morning. ½ Candez Morning 1/2 Digoxin AM: Febuxostat AM: Renakult - Nursing Case Study
Pathophysiology
• Primary mechanism: Ischemic stroke likely caused by an embolism or thrombosis, resulting in damage to the brain areas controlling the right hand, leading to persistent hemiparesis. This damage impairs motor function due to the disruption of neural pathways.
• Secondary mechanism: Chronic hypertension likely contributed to the initial stroke by causing vascular damage, which increases the risk of atherosclerosis and embolism formation. Ongoing hypertension management is critical to prevent further cardiovascular events.
• Key complication: The patient's chronic medication use over 15 years for stroke and hypertension management may have led to progressive renal impairment, exacerbating fluid retention and contributing to pulmonary issues such as Community Acquired Pneumonia. This highlights the importance of monitoring renal function and adjusting medications as needed to prevent further complications.
Patient Profile
Demographics:
• Age: 67
• Gender: Female
• Relevant occupation: Former tailor
History:
• Key past medical history:
• Stroke 15 years ago affecting right hand and speech
• Community Acquired Pneumonia in 2025
• Kidney disease
• Hypertension
• Fluid in left liver, drained
• Current medications:
• AM: ½ Cardiosel (Metoprolol)
• PM: Apixaban ½
• PM: Amlodipine
• Morning: ½ Tapazole
• AM: Apixaban ½
• Morning: ½ Candesartan
• Morning: ½ Digoxin
• AM: Febuxostat
• AM: Renakult
• Allergies: None reported
Current Presentation:
• Chief complaint: Difficulty breathing
• Key symptoms: Shortness of breath, occasional difficulty communicating, limited mobility in right hand
• Vital signs: Critically abnormal (specific values not available)
Section 1
As the healthcare team continues to monitor the patient, new complications arise. During a routine assessment, the patient exhibits signs of worsening respiratory distress, characterized by increased shortness of breath and diminished breath sounds upon auscultation. Vital signs reveal tachypnea with a respiratory rate of 28 breaths per minute and an oxygen saturation dropping to 88% on room air, necessitating supplemental oxygen to maintain adequate levels. Additionally, the patient is noted to have an irregular heartbeat with a pulse of 110 beats per minute and blood pressure readings fluctuating between 160/95 mmHg, indicating poorly controlled hypertension despite medication adherence.
In response to the patient's deteriorating respiratory status, a chest X-ray is conducted, revealing bilateral infiltrates suggestive of pulmonary edema, likely secondary to her compromised renal function and fluid overload. Laboratory tests indicate an elevated B-type natriuretic peptide (BNP) level at 600 pg/mL, confirming the suspicion of heart failure exacerbation. Renal function tests show a creatinine level of 2.2 mg/dL and a blood urea nitrogen (BUN) of 45 mg/dL, further indicating renal insufficiency. These findings necessitate a re-evaluation of her current medication regimen, particularly the use of digoxin and other renal-excreted drugs, to prevent further deterioration of her renal and cardiac status.
The healthcare team faces the complex challenge of balancing the management of her cardiac and renal conditions while addressing the acute respiratory compromise. This situation requires advanced clinical reasoning to adjust her treatment plan, optimize diuretic therapy, and potentially initiate renal replacement therapy if her renal function continues to decline. The focus now shifts to stabilizing her acute symptoms while preventing further complications, highlighting the critical need for close monitoring and interdisciplinary collaboration in her care plan.
Section 2
As the healthcare team continues to address the patient's multifaceted condition, a critical change in her status prompts immediate attention. During a subsequent assessment, the patient's respiratory distress intensifies, with her oxygen saturation plummeting to 82% despite being on supplemental oxygen at 4 liters per minute via nasal cannula. Her respiratory rate escalates to 32 breaths per minute, and she exhibits signs of increased work of breathing, including nasal flaring and use of accessory muscles. The patient is visibly anxious and expresses a feeling of impending doom, which is compounded by her irregular heart rhythm, now characterized by frequent premature ventricular contractions (PVCs).
In light of these developments, an urgent arterial blood gas (ABG) analysis is conducted, revealing a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, indicating acute respiratory acidosis with significant hypoxemia. Concurrently, a repeat chest X-ray shows a progression of the bilateral infiltrates, and an echocardiogram displays reduced ejection fraction, confirming worsening heart failure. Given the patient's declining renal function, as evidenced by a further increase in creatinine to 2.5 mg/dL and BUN to 50 mg/dL, the team is faced with the challenge of managing her fluid status without exacerbating her renal impairment.
This scenario necessitates a rapid adjustment of her management plan. The team considers initiating non-invasive positive pressure ventilation (NIPPV) to improve ventilation and oxygenation, while carefully titrating diuretics to manage fluid overload. Additionally, the possibility of initiating renal replacement therapy is discussed in anticipation of further renal decline. The healthcare team must employ advanced clinical reasoning to balance these interventions, aiming to stabilize her immediate symptoms while preventing further complications. This complex interplay of cardiac, respiratory, and renal issues underscores the need for continuous monitoring and a dynamic, interdisciplinary approach to her care.
Section 3
Following the initiation of non-invasive positive pressure ventilation (NIPPV), the healthcare team observes a gradual improvement in the patient's respiratory parameters. Her oxygen saturation climbs to 90%, and her respiratory rate decreases to 28 breaths per minute, indicating a positive response to the intervention. However, she remains tachypneic and continues to use accessory muscles, necessitating ongoing monitoring. The patient's anxiety slightly diminishes as her breathing stabilizes, yet she still communicates a sense of unease, suggesting a need for further assessment and support.
Despite the improved oxygenation, a repeat set of laboratory tests reveals an alarming rise in potassium levels, now at 6.2 mmol/L, likely a consequence of her compromised renal function and the use of specific medications. This hyperkalemia poses a critical risk of exacerbating her cardiac irregularities, notably the premature ventricular contractions (PVCs) that have persisted. The team promptly initiates measures to address the hyperkalemia, including the administration of calcium gluconate to stabilize cardiac membranes and insulin with glucose to facilitate the intracellular shift of potassium.
The team is faced with the challenge of balancing her fluid status without further aggravating her renal impairment. An interdisciplinary discussion highlights the need to carefully titrate diuretics, while considering the initiation of renal replacement therapy if her renal function continues to deteriorate. As the patient's clinical picture evolves, the healthcare team must remain vigilant, continuously assessing her response to interventions and adjusting the management plan to prevent further complications, all while preparing for potential escalation of care.
Section 4
Change in Patient Status:
Over the next 24 hours, the patient's condition reveals a mixed trajectory. Her respiratory function continues to show signs of improvement, with oxygen saturation levels stabilizing around 94% and a respiratory rate settling at 24 breaths per minute. However, the clinical team notes a new development: the patient exhibits mild confusion and disorientation, raising concerns about her neurological status. A focused neurological assessment reveals a subtle decrease in her Glasgow Coma Scale score, now at 13, with particular deficits in verbal response and eye-opening. This change prompts an urgent consideration of potential causes, including electrolyte imbalance, hypoxia, or medication side effects.
Simultaneously, the patient's cardiac rhythm displays increased irregularities, with frequent PVCs noted on telemetry monitoring. The team suspects that her persistent hyperkalemia, despite initial management, may be contributing to this instability. Repeat laboratory work confirms the potassium level remains elevated at 5.8 mmol/L. In response, the healthcare team intensifies their efforts to address electrolyte imbalances, adjusting her medication regimen to decrease potassium-retaining agents and considering the addition of sodium polystyrene sulfonate to facilitate potassium excretion.
As the day progresses, the patient starts complaining of mild chest discomfort and palpitations, indicating a possible exacerbation of her cardiac condition. Vital signs show a blood pressure of 150/90 mmHg, a heart rate of 110 beats per minute with irregular rhythm, and a temperature of 37.2°C. With these developments, the team remains alert to potential complications such as cardiac ischemia or further neurological decline, prioritizing continuous monitoring and readiness to escalate care, including the possible initiation of renal replacement therapy if her renal function worsens. This dynamic situation requires the healthcare team to integrate complex data, anticipate evolving complications, and ensure the patient receives comprehensive, adaptive care.
Section 5
New Diagnostic Results:
As the healthcare team diligently monitors the patient's evolving condition, they decide to conduct a series of diagnostic tests to better understand the underlying issues contributing to her recent symptoms. A repeat complete blood count (CBC) and comprehensive metabolic panel (CMP) are ordered, alongside a brain CT scan to evaluate any potential neurological causes for her confusion and disorientation. The blood work reveals a worsening renal function, with her creatinine level rising to 2.1 mg/dL and an increased blood urea nitrogen (BUN) of 45 mg/dL, suggestive of acute kidney injury superimposed on her chronic kidney disease. Her sodium level is slightly decreased at 133 mmol/L, raising the possibility of dilutional hyponatremia.
The brain CT scan, however, shows no acute intracranial abnormalities, providing some reassurance that her neurological symptoms may be more related to metabolic disturbances rather than a new stroke or bleed. The team also reviews the recent telemetry data, which continues to show frequent premature ventricular contractions (PVCs) and occasional runs of ventricular tachycardia, indicating significant cardiac irritability likely exacerbated by her electrolyte imbalances.
In light of these findings, the healthcare team recognizes the need for a multi-pronged approach to address her complex clinical picture. They initiate a gentle diuretic regimen to manage her fluid overload while cautiously correcting her electrolyte imbalances. Additionally, they consider adjusting her medication regimen to mitigate any nephrotoxic effects and explore the potential role of renal replacement therapy if her renal function continues to decline. This comprehensive strategy aims to stabilize her condition and prevent further complications, acknowledging the intricate interplay between her cardiac, renal, and neurological systems.